Uterine corpus endometrial carcinoma patients with PHF6 mutations had a favourable prognosis in terms of OS (p = 0.021) and DFI (p = 0.031) compared with patients without PHF6 mutations (Figure 1D,E). This evidence concerns the gene PHF6 and uterine corpus endometrial carcinoma.